Trials / Not Yet Recruiting
Not Yet RecruitingNCT06370442
Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- State University of New York - Upstate Medical University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if intranasal dexmedetomidine could be an alternative to the current standard of care (injectable benzodiazepines or antipsychotics) for sedation prior to computerized tomography (CT) or magnetic resonance imaging (MRI) in those greater than or equal to 65 years of age (older adults) that are seen in the Emergency Department (ED).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Intranasal dexmedetomidine, 100mcg |
| DRUG | Lorazepam | 0.5mg IV |
| DRUG | Haloperidol | 0.5mg IV |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-05-31
- Completion
- 2025-09-01
- First posted
- 2024-04-17
- Last updated
- 2024-04-22
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06370442. Inclusion in this directory is not an endorsement.